Implication of Fluid Strategies Upon Hepatic Outcome in Hepatobiliary Surgery

NCT03923816 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2019-04-23

No results posted yet for this study

Summary

compare the effect of two different protocol of fluid therapy in patients undergoing elective hepatobiliary surgery under general anesthesia regarding hemodynamics and SGPT change pre- and postoperative.

Conditions

  • Hepatic Complication

Interventions

DRUG

Conservative fluid strategy: 12 mL/kg/h of Lactated Ringer (LR).&Restrictive fluid strategy:6 mL/kg/h of Lactated Ringer (LR).

comparison of two intraoperative fluid strategies upon hepatic outcome in hepatobiliary surgery

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Emad Zarief, assistant professor · Assiut University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-01
Primary Completion
2020-10-01
Completion
2021-10-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03923816 on ClinicalTrials.gov